Finnish research group discovers a new immune system regulator
Regulatory T cells are critical controllers of the immune response. The majority of T cells boost the immune response enhancing the ability to destroy cancer cells, viruses and bacteria.
In contrast, regulatory T cells can sometimes suppress the immune system's ability to attack cancer cells, allowing cancer to grow and spread.
In these instances, inhibiting or braking the regulatory T cell activity would be needed.
-We discovered that a protein called 'Hypermethylated In Cancer 1', or HIC1, serves as the key regulator of regulatory T cells controlling the expression of a large set of genes contributing to T cell function, says Academy Professor Riitta Lahesmaa.
– In addition, with genome-wide methods we show that HIC1 binds to sites in the nucleus that often contain genetic variations associated with immune-mediated diseases. This gives us completely new insights into molecular mechanisms that regulate T cell function and immune response in general, continues Lahesmaa.
###
The study was published in the Cell Reports journal on 20 February 2018.
Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells, available online: http://www.
Media Contact
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Going Green: Fighting Freshwater Salt Pollution with Phytoremediation
Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…
Psoriasis Patients at Increased Risk for Crohn’s Due to Gut Inflammation
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes…
Popular Weight-Loss Drugs—Beneficial or Risky?
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems Growing Public Demand for GLP-1RA Weight-Loss Medications Demand for weight-loss medications sold under…